MDNews - Long Island

June 2012

Issue link: https://viewer.e-digitaledition.com/i/67940

Contents of this Issue

Navigation

Page 23 of 31

SPECIAL FEATURE ON THE MARK AT THE WOUND HEALING CENTER at Winthrop-University Hospital, the use of microbiology and pathology to better develop clinical treatments and improve patient outcomes is serving as a gateway to targeting chronic wounds at a genetic level. Harold Brem, M.D., FACS, Chief of the Division of Wound Healing and Regenerative Medicine at Winthrop-University Hospital, explains that he and his colleagues had long encountered a puzzling scenario: One wound treated with debridement and a specific therapy would heal, yet another wound addressed in the same manner would result in the callus returning and the wound remaining prone to infection. The dilemma led to the establishment of the Wound Genome Project. The endeavor, which is a joint effort of Dr. Brem and his research partner Marjana Tomic-Canic, Ph.D., set out to identify the genetic markers that could contribute to the discrepancy in patients' courses of healing. The research team discovered that there are, in fact, specific genes — the oncogene c-myc and b-catenin pathways — that can be triggered by bacteria and pressure associated with chronic wounds to send signals to the body that ultimately inhibit the healing process. In 2005, the Wound Genome Project earned a grant from the National Institutes of Health to further investigate the genetic component of healing, as well as its relevance to clinical practice. According to Dr. Brem, the potential application as a prognostic and diagnostic tool for evaluating patients is enormous. about patients' care. Specialists convene weekly with the heads of emergency medicine and radiology and Virginia M. Donovan, M.D., Chair of the Department of Pathology at Winthrop-University Hospital, to discuss each patient. The addi- tion of pathology to this multidisciplinary review represents one of the crucial principles of the Wound Healing Center's approach: Wounds are not judged on face value, but on their microbiologic makeup. "Like an oncology program, we at the Wound Healing Center actually look at the biopsy of the tissue left behind to develop a treatment plan," says Dr. Brem. "A clinician can't judge a wound by how it looks alone. We only consider the wound treatment by the pathology and microbiology reports. It's not the tissue removed that counts. It's the tissue left behind that is the clue to the healing process." In fact, clinical investigations comparing the outcomes of cases treated based on evaluation of a wound's appearance and the results of cases treated with pathological information demonstrate that clinicians are incorrect in their determinations 28% of the time when relying simply on a wound's appearance. Thus, each case's evaluation includes a tissue biopsy that allows Dr. Donovan and her team to analyze the biologic factors of the wound. The pathology reports open the door to the Wound Healing Center's expert application of regenerative medicine therapies — an option available to every patient. These therapies include Thomas Davenport, M.D., and a patient discuss her progress. 24 | Long Island MD NEWS ■ MDNEWS.COM endogenous stem cells, human growth factors, fibroblasts, keratinocytes and platelet-rich plasma that stimulate the wound's healing at a cellular level. The regenerative medicine focus stems from Dr. Brem's background in the clinical study of how blood vessels grow and heal — and exploration into the field of angiogenesis — and has proven extremely effective. One such treatment is Apligraf. Although it appears to be a skin graft, it is actually a human, bilayer cell therapy containing stem cells. When applied to leg and venous ulcers, in conjunction with proper debridement, antibiotics and cleaning, it can achieve curative outcomes in 90% to 95% of cases. The HBO2 Solution The Wound Healing Center may also incorporate hyperbaric medicine as a supplemental measure for certain patients. Regenerative medicine thera- pies rely on scientific evidence that suggests exposure to 100% oxygen in a pressurized environment can improve blood flow to wounds such as diabetic foot ulcers, pressure ulcers and those with bone infection. In their initial evaluations and subsequent pathology examinations, patients' conditions are assessed according to indications dictated by the Undersea & Hyperbaric Medical Society. The Winthrop- University Hospital Wound Program has two dedicated board-certified hyperbaric medicine physicians. "We look for pathological or histo- logical signs of ischemia, meaning that there is low blood flow to the wound itself," says Dr. Gorenstein. "Even though the vascular testing sometimes shows that there is adequate blood flow, we have evidence that there's ischemia, which indicates decreased blood flow. Based on that pathology, we can then guide our therapy and determine whether a patient is going to benefit from hyperbarics, which can reverse some of the tissue hypoxia." Located in Winthrop-University Hospital's main building, the Hyperbaric Medicine Department recently marked its 10,000th treatment. Physicians and hyperbaric technicians who perform the customized treatments staff the facility. Patients typically undergo

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Long Island - June 2012